BA
Baumer S.A.
BALM4.SA · SAO
R$ 14.80 -0.67% (-R$ 0.10)
1M -8.59%
Market Cap R$ 144.8M
P/E Ratio 7.52x
Div. Yield 38.10%
ROE 11.38%
Bulios Fair Price
R$ 20.76
40.3% upside
Current Price
R$ 14.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BALM4.SA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap EV/EBITDA 2.84x
P/S 0.68x
P/B 0.91x
Growth
46 /100
Stable Rev. growth 13.40%
Book val. growth 4.65%
EPS growth 46.37%
Profitability
85 /100
Strong Net margin 9.07%
Op. margin 18.96%
FCF margin 20.99%
Quality
68 /100
Excellent ROE 11.38%
ROA 6.83%
Asset turnover 0.75x
Debt
85 /100
Low Current ratio 2.37x
Int. coverage 1.86x
Net debt/EBITDA 0.08x
Stability
28 /100
Unstable Rev. volatility 35.01%
EPS volatility 151.82%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BALM4.SA
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Ruy Baumer
Employees
6
Headquarters
Mogi Mirim